Granules India Limited Valid
CEP Certificates (EDQM COS List)
Granules India Limited Valid
CEP Database
Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.
- Total Records 21
- Latest End Date -
- Data Source EDQM
- Last Updated 2026-01-13
Company Overview
Company
Granules India Limited Valid
Country
India
Website
Social Profiles
Company Snapshot
Granules India Limited Valid
2nd Floor, 3rd Block, My Home Hub, Madhapur, Hyderabad- 500 081 (TG)
India
granulesindia.com/ mail@granulesindia.com View on MapCEP Records Timeline (21 records)
Product
Atazanavir sulfate, Micronised and non-micronised, form A
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2020-279 - Rev 02
Substance No.
2898
Issue Date
2026-01-13
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2020-279 - Rev 02
Substance No.: 2898
Product
Sorafenib tosilate
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2022-386 - Rev 01
Substance No.
2931
Issue Date
2025-10-10
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-386 - Rev 01
Substance No.: 2931
Product
Metoprolol succinate
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2019-232 - Rev 04
Substance No.
1448
Issue Date
2025-10-01
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2019-232 - Rev 04
Substance No.: 1448
Product
Paracetamol
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 1998-047 - Rev 07
Substance No.
49
Issue Date
2025-09-02
End Date
-
Country
India
Identifiers
Certificate No.: CEP 1998-047 - Rev 07
Substance No.: 49
Product
Guaifenesin, BPL site
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2021-332 - Rev 01
Substance No.
615
Issue Date
2025-09-02
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-332 - Rev 01
Substance No.: 615
Product
Metformin Hydrochloride, BPL Site
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2018-120 - Rev 02
Substance No.
931
Issue Date
2025-09-02
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-120 - Rev 02
Substance No.: 931
Product
Levetiracetam
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2023-138 - Rev 01
Substance No.
2535
Issue Date
2025-08-29
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2023-138 - Rev 01
Substance No.: 2535
Product
Omeprazole
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2022-406 - Rev 01
Substance No.
942
Issue Date
2025-08-29
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-406 - Rev 01
Substance No.: 942
Product
Pantoprazole sodium sesquihydrate, Form-I
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2022-383 - Rev 01
Substance No.
2296
Issue Date
2025-08-29
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-383 - Rev 01
Substance No.: 2296
Product
Esomeprazole magnesium trihydrate
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2022-012 - Rev 03
Substance No.
2372
Issue Date
2025-08-28
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-012 - Rev 03
Substance No.: 2372
Product
Trazodone hydrochloride
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2023-010 - Rev 01
Substance No.
2857
Issue Date
2025-08-28
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2023-010 - Rev 01
Substance No.: 2857
Product
Gliclazide
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2017-240 - Rev 03
Substance No.
1524
Issue Date
2025-08-27
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2017-240 - Rev 03
Substance No.: 1524
Product
Metformin Hydrochloride, Unit-IV Site
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2021-312 - Rev 02
Substance No.
931
Issue Date
2025-08-27
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-312 - Rev 02
Substance No.: 931
Product
Rifaximin, [RSA code] Process-II
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2021-377 - Rev 02
Substance No.
2362
Issue Date
2025-08-27
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-377 - Rev 02
Substance No.: 2362
Product
Losartan potassium, Process II, Form-I
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2020-333 - Rev 05
Substance No.
2232
Issue Date
2025-08-27
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2020-333 - Rev 05
Substance No.: 2232
Product
Guaifenesin
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2009-201 - Rev 04
Substance No.
615
Issue Date
2025-08-25
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2009-201 - Rev 04
Substance No.: 615
Product
Metformin Hydrochloride
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2004-124 - Rev 08
Substance No.
931
Issue Date
2025-08-25
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2004-124 - Rev 08
Substance No.: 931
Product
Cetirizine dihydrochloride
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2009-349 - Rev 03
Substance No.
1084
Issue Date
2025-08-25
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2009-349 - Rev 03
Substance No.: 1084
Product
Pirfenidone
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2016-288 - Rev 02
Substance No.
2856
Issue Date
2025-08-25
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2016-288 - Rev 02
Substance No.: 2856
Product
Rifaximin
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
CEP 2012-146 - Rev 02
Substance No.
2362
Issue Date
2024-06-10
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-146 - Rev 02
Substance No.: 2362
Product
Penicillamine
Substance
GRANULES INDIA LIMITED Hyderabad IN
Certificate No.
R0-CEP 2020-391 - Rev 00
Substance No.
566
Issue Date
2023-01-17
End Date
-
Country
India
Identifiers
Certificate No.: R0-CEP 2020-391 - Rev 00
Substance No.: 566
Status Breakdown
21 total- Valid
Official Source
All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).
Visit EDQMRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Country
India
Identifiers
Certificate No.: CEP 2020-279 - Rev 02
Substance No.: 2898
100% Official Data
Directly from the EDQM CEP database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.